JPWO2024084852A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2024084852A5 JPWO2024084852A5 JP2024551314A JP2024551314A JPWO2024084852A5 JP WO2024084852 A5 JPWO2024084852 A5 JP WO2024084852A5 JP 2024551314 A JP2024551314 A JP 2024551314A JP 2024551314 A JP2024551314 A JP 2024551314A JP WO2024084852 A5 JPWO2024084852 A5 JP WO2024084852A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- encoding
- acid residue
- domain
- codon encoding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022168686 | 2022-10-20 | ||
| JP2022168686 | 2022-10-20 | ||
| PCT/JP2023/032627 WO2024084852A1 (ja) | 2022-10-20 | 2023-09-07 | Carをコードする核酸分子とそれを含むベクター、car、carを含む免疫細胞とその細胞を含む医薬組成物、並びにcarを含む免疫細胞の製造方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2024084852A1 JPWO2024084852A1 (https=) | 2024-04-25 |
| JPWO2024084852A5 true JPWO2024084852A5 (https=) | 2025-06-05 |
| JP7829895B2 JP7829895B2 (ja) | 2026-03-16 |
Family
ID=90737692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024551314A Active JP7829895B2 (ja) | 2022-10-20 | 2023-09-07 | Carをコードする核酸分子とそれを含むベクター、car、carを含む免疫細胞とその細胞を含む医薬組成物、並びにcarを含む免疫細胞の製造方法 |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP4606897A1 (https=) |
| JP (1) | JP7829895B2 (https=) |
| CN (1) | CN119998452A (https=) |
| WO (1) | WO2024084852A1 (https=) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL104570A0 (en) | 1992-03-18 | 1993-05-13 | Yeda Res & Dev | Chimeric genes and cells transformed therewith |
| RU2018127657A (ru) * | 2015-12-30 | 2020-01-31 | Новартис Аг | Виды терапии на основе иммуноэффекторных клеток с улучшенной эффективностью |
| CA3031289A1 (en) * | 2016-07-18 | 2018-01-25 | Helix Biopharma Corp. | Car immune cells to treat cancer |
| WO2018225732A1 (ja) | 2017-06-05 | 2018-12-13 | 国立大学法人三重大学 | Mage-a4由来ペプチドを認識する抗原結合性タンパク質 |
| CN113980137B (zh) * | 2020-07-27 | 2023-08-22 | 中国科学院分子细胞科学卓越创新中心 | 一种包含CD3ε胞内碱性氨基酸富集区基序的嵌合抗原受体及其用途 |
| JP7691234B2 (ja) * | 2020-12-25 | 2025-06-11 | シスメックス株式会社 | 抗体の抗原に対する親和性を向上させる方法及びその利用 |
-
2023
- 2023-09-07 CN CN202380073124.XA patent/CN119998452A/zh active Pending
- 2023-09-07 EP EP23878387.2A patent/EP4606897A1/en active Pending
- 2023-09-07 JP JP2024551314A patent/JP7829895B2/ja active Active
- 2023-09-07 WO PCT/JP2023/032627 patent/WO2024084852A1/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112029001B (zh) | 靶向nk激活性受体的嵌合抗原受体 | |
| CA3098995C (en) | Humanized bcma antibody and bcma-car-t cells | |
| JP2021087455A5 (https=) | ||
| JP2023103451A (ja) | 改善された二重特異性ポリペプチド分子 | |
| CN110662771A (zh) | 一种结合bcma的嵌合抗原受体(car)及其应用 | |
| JP2021094037A5 (https=) | ||
| JP2020506700A5 (https=) | ||
| JP2020511529A5 (https=) | ||
| FI3823665T3 (fi) | BCMA-spesifisiä kimeerisiä antigeenireseptoreita ja niiden käyttöjä | |
| JP2023053328A5 (https=) | ||
| JP2022501043A5 (https=) | ||
| JP2021505131A5 (https=) | ||
| JP2023534808A5 (https=) | ||
| JP2020513829A5 (https=) | ||
| JP2021520788A5 (https=) | ||
| IL264144B1 (en) | Antibody 18a2 against claudin and its use | |
| JP2019516352A5 (https=) | ||
| JP2025024031A5 (https=) | ||
| JP2018526028A5 (https=) | ||
| JP2018525033A5 (https=) | ||
| JP2021532742A5 (https=) | ||
| JP2024518378A5 (https=) | ||
| JP2021514631A5 (https=) | ||
| JP2022542559A5 (https=) | ||
| JP2023549098A5 (https=) |